A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The presence of P+PBac{XP5.WH5}BSC780 was verified using the PCR methods and primers described in FBrf0175003.
The breakpoints of Df(2R)BSC780 predicted from the Release 5 genomic coordinates of the progenitor PBac{WH}CG11406f05598 and P{XP}Mmp1d03549 transposable element insertion sites are 2R:20090739 ;20572714 and the cytological breakpoints predicted from these coordinates are 60C2;60D14.